ONC1-0013B
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for ONC1-0013B, covering 2017-07-11 to 2017-07-11. Get the full timeline:
Most recent: Clinical Trial Update: Safety, Tolerability and Pharmacokinetics of ONC1-0013B in Patients With Progressive Metastatic Castration-resistant Prostate Cancer [Phase 1]